GFAP immunoreactivity in dorsal striatum
Treatment | Total number of astrocytes | % of control number astrocytes | Total number of clusters | % of control number of clusters |
---|---|---|---|---|
Saline | 11 ± 2.2 | 100 ± 18.5 | 3 ± 0.8 | 100 ± 45.1 |
Paraquat (10 mg/kg) | 20 ± 5.4 | 169 ± 46 | 4 ± 0.88 | 130 ± 26.5 |
Maneb (30 mg/kg) | 19 ± 4.3 | 161 ± 36.5 | 5 ± 0.62 | 140 ± 18.4 |
Paraquat + maneb | 44 ± 11* | 373 ± 98.2* | 9 ± 1.4*,†,1-159 | 275 ± 42*,†,1-159 |
Numbers of reactive astrocytes 1 (n = 6), PQ (10 mg/kg; n = 6), MB (30 mg/kg; n = 6), and PQ + MB (n = 5) groups. Bonferroni–Dunnpost hoc analysis indicates significant differences from either control paraquat alone or maneb alone.
Significantly different:
↵* , from control;
↵† , from paraquat alone;
↵F1-159 , from maneb alone.